|
[Related PubMed/MEDLINE]
Total Number of Papers: 30
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2022 |
Impact of SLCO1B1*5 on Flucloxacillin and Co-Amoxiclav-Related Liver Injury. |
ALP, DILI, POPRES, SLCO1B1, ULN |
| 2 |
2022 |
Outcomes of keratolimbal allograft from ABO compatible donors for severe bilateral limbal stem cell deficiency. |
DSA, IVIG, KLAL, LSCD, PRA, SI |
| 3 |
2020 |
Association between elevation of plasma biomarkers and monocyte dysfunction and their combination in predicting sepsis: An observational single-centre cohort study. |
PCT, PD-L1 |
| 4 |
2020 |
Development and validation of a universal blood donor genotyping platform: a multinational prospective study. |
HPA, RBC |
| 5 |
2020 |
HLA-DRB1 allele distribution among children with rheumatic heart disease in Haji Adam Malik Hospital Medan, Indonesia. |
RHD, SSP |
| 6 |
2014 |
Human herpesvirus 6B immediate-early I protein contains functional HLA-A*02, HLA-A*03, and HLA-B*07 class I restricted CD8(+) T-cell epitopes. |
BMT, HHV-6B |
| 7 |
2011 |
Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection. |
HCV |
| 8 |
2010 |
A rapid sample method for HLA haplotype typization. A preliminary study on celiac patients. |
PCR |
| 9 |
2010 |
Critical parameters in blood processing for T-cell assays: validation on ELISpot and tetramer platforms. |
ELISPOT, IFN, PBMC |
| 10 |
2010 |
Long-term follow-up of a pilot study using a chemotherapy-alone protocol for killer Ig-like receptor-ligand-mismatched haploidentical haematopoietic SCT. |
HSCT, KIR |
| 11 |
2010 |
The evolution and clinical impact of human leukocyte antigen technology. |
--- |
| 12 |
2009 |
Cord blood transplantation in adults. |
CBT |
| 13 |
2005 |
Basic mechanisms of humoral rejection. |
--- |
| 14 |
2005 |
Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation. |
DSA, ELISA, MMF |
| 15 |
2005 |
Human leukocyte antigens in indigenous (mapuche) people in a regional renal transplantation program in chile. |
--- |
| 16 |
2003 |
HLA class II antigen expression in uveal melanoma: correlation with clinicopathological features. |
--- |
| 17 |
1997 |
Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis. |
AMN, CCER, CER, X-ALD |
| 18 |
1996 |
Neonatal thrombocytopenia caused by passive transfer of anti-PLA1 antibody by blood transfusion. |
--- |
| 19 |
1994 |
Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone marrow counterparts? |
BM, CB, HPC, SCF |
| 20 |
1994 |
Primitive hematopoietic progenitor cells are present in peripheral blood autografts. |
C-HGF, G-CSF, GM-CSF, HPC, IL-3, LTC-IC, PB |
| 21 |
1991 |
Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. |
--- |
| 22 |
1990 |
A simplified cellular ELISA (CELISA) for the detection of antibodies reacting with cell-surface antigens. |
CELISA, CELISA, EIA, sIg |
| 23 |
1990 |
HLA associations in patients with polycystic ovaries and in patients with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. |
CAH, PCO, SV, SW |
| 24 |
1989 |
Macrophages, lymphocytes and major histocompatibility complex (HLA) class II antigens in adult human sensory and sympathetic ganglia. |
--- |
| 25 |
1988 |
Transient platelet and HLA antibody formation in multitransfused patients with malignancy. |
--- |
| 26 |
1987 |
Immunogenetic aspects of preeclampsia. |
MHC, PE |
| 27 |
1986 |
Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules. |
IL-2, mAb |
| 28 |
1981 |
Human leukocyte anitgen in torticollis and other idiopathic dystonic syndromes. |
--- |
| 29 |
1977 |
HLA antigens and toxoplasmic retinochoroiditis. |
--- |
| 30 |
1976 |
Cessation of immunosuppression after renal transplantation. |
MLC |
|
A Search Service for Abbreviation / Long Form
